Stocks and Investing
Stocks and Investing
Wed, October 31, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, October 30, 2018
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Initiated (ADMA) at Strong Buy and Held Target at $17 on, Oct 30th, 2018
Raghuram Selvaraju of HC Wainwright & Co., Initiated "ADMA Biologics, Inc." (ADMA) at Strong Buy and Held Target at $17 on, Oct 30th, 2018.
Raghuram has made no other calls on ADMA in the last 4 months.
There are 2 other peers that have a rating on ADMA. Out of the 2 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Reni Benjamin of "Raymond James" Maintained at Buy with Decreased Target to $10 on, Friday, October 12th, 2018
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $12 on, Friday, July 27th, 2018
Contributing Sources